PALISADE BIO, INC. (PALI) Operating income 2016–2025
PALISADE BIO, INC. (PALI) annual operating income history from SEC filings — each fiscal year as reported.
-$18.1MFY2025 · since FY2016: -$20.6M → -$18.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$18.1M | -21.5% |
| FY2024 | -$14.9M | -13.7% |
| FY2023 | -$13.1M | +16.9% |
| FY2022 | -$15.7M | +62.4% |
| FY2021 | -$41.9M | -350.2% |
| FY2020 | -$9.3M | -7.7% |
| FY2019 | -$8.6M | -4.5% |
| FY2018 | -$8.3M | +37.9% |
| FY2017 | -$13.3M | +35.5% |
| FY2016 | -$20.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PALI financial trends
PALI RevenuePALI Net incomePALI Net marginPALI Gross profitPALI Gross marginPALI Operating marginPALI Operating cash flowPALI Free cash flowPALI Capital expendituresPALI Return on equityPALI Stock buybacksPALI Dividends paidPALI Total assetsPALI Total liabilitiesPALI Shareholders’ equityPALI overview →